Header Logo

Connection

MARK MANARY to Rifamycins

Back to Details
This is a "connection" page, showing publications MARK MANARY has written about Rifamycins.
MARK MANARY
Connection Strength
0.346
Rifamycins
  1. A randomized, double-blind, placebo-controlled trial of rifaximin, a nonabsorbable antibiotic, in the treatment of tropical enteropathy. Am J Gastroenterol. 2009 Sep; 104(9):2326-33.
    View in: PubMed
    Score: 0.346
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.